Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01GY1325A and 01GY1325B)
Received: 9 March 2020
Accepted: 4 August 2020
First Online: 20 August 2020
Ethics approval and consent to participate
: The WorkSafeMed study with all its components was approved by the responsible ethics committees of the medical faculties of the University Hospital in Bonn (reference number: #350/14) and the University Hospital in Tuebingen (reference number: #547/2014BO1). Each partner complied with confidentiality requirements according to German law. Informed verbal consent was sought from participants, who were informed that the study was voluntary and that they could withdraw at any time. The need for written consent is deemed unnecessary according to national regulations. The method of acquiring consent was approved by the ethics committees.
: Informed verbal consent was sought from participants. All participants consented to have the results published as part of the informed consent process. The participants were assured of their confidentiality. The need for written consent is deemed unnecessary according to national regulations. The method of acquiring consent was approved by the ethics committees.
: The authors declare that they have no competing interests.